Sunil Badve(@Badves) 's Twitter Profileg
Sunil Badve

@Badves

Nephrologist, Conjoint Professor of Medicine @UNSWMedicine @georgeinstitute. 'Science is a way of thinking much more than it is a body of knowledge.' Carl Sagan

ID:940672430

calendar_today11-11-2012 06:22:25

3,2K Tweets

1,3K Followers

893 Following

JACC Journals(@JACCJournals) 's Twitter Profile Photo

The new 2023 ACC/AHA/ACCP/HRS Guideline-at-a-Glance highlights the new classification system of AF, which identifies AF as a disease continuum that requires a variety of strategies at different stages. Learn more: bit.ly/3sYdow8

The new 2023 ACC/AHA/ACCP/HRS #AFib Guideline-at-a-Glance highlights the new classification system of AF, which identifies AF as a disease continuum that requires a variety of strategies at different stages. Learn more: bit.ly/3sYdow8 #ClinicalGuidelines #CardioTwitter
account_circle
Edgar V. Lerma ๐Ÿ‡ต๐Ÿ‡ญ(@edgarvlermamd) 's Twitter Profile Photo

RENAL LIFECYCLE Trial: Efficacy and safety of dapagliflozin 10 mg vs placebo
โœ… eGFR <25
โœ… Patients on dialysis with residual diuresis >500 ml/24-hour
โœ… Kidney transplant recipients with an eGFR </=45

๐Ÿ“Œ PRIMARY ENDPOINT: Composite end point of kidney failure,โ€ฆ

RENAL LIFECYCLE Trial: Efficacy and safety of dapagliflozin 10 mg vs placebo #Nephpearls โœ… eGFR <25 โœ… Patients on dialysis with residual diuresis >500 ml/24-hour โœ… Kidney transplant recipients with an eGFR </=45 ๐Ÿ“Œ PRIMARY ENDPOINT: Composite end point of kidney failure,โ€ฆ
account_circle
Vlado Perkovic(@VladoPerkovic) 's Twitter Profile Photo

Big news: the FLOW trial of semaglutide for kidney protection in CKD stopped at pre-planned interim analysis. Trial now to close out and results will be available in first half of 2024.

Big news: the FLOW trial of semaglutide for kidney protection in CKD stopped at pre-planned interim analysis. Trial now to close out and results will be available in first half of 2024. #FLOWtrial #semaglutide #ozempic
account_circle
Jeffrey Ha(@_jeffreyha) 's Twitter Profile Photo

Our systematic review in AJKD - CKD should be regarded as an independent risk factor for new-onset atrial fibrillation. We should consider screening for AF in CKD @badves
Dearbhla Kelly Brendon Neuen Min Jun Vlado Perkovic ajkd.org/article/S0272-โ€ฆ

account_circle
Brendon Neuen(@brendonneuen) 's Twitter Profile Photo

Great work by The George Institute for Global Health PhD fellow Jeffrey Ha - systematically defining the progressive, graded increase in risk of atrial fibrillation as kidney function declines and as albuminuria increases

Now out in AJKD: ajkd.org/article/S0272-โ€ฆ

Great work by @georgeinstitute PhD fellow @_jeffreyha - systematically defining the progressive, graded increase in risk of atrial fibrillation as kidney function declines and as albuminuria increases Now out in @AJKDonline: ajkd.org/article/S0272-โ€ฆ
account_circle
Vlado Perkovic(@VladoPerkovic) 's Twitter Profile Photo

Big news: PROTECT trial data re Sparsentan vs irbesartan in IgAN announced. 40% reduction in proteinuria sustained out to 2 years, clear reduction in chronic eGFR slope by 1.1 mls/min/yr (p=0.037). Total eGFR slope diff 1.0 mls/min/yr, p=0.058.ir.travere.com/news-releases/โ€ฆ

Big news: PROTECT trial data re Sparsentan vs irbesartan in IgAN announced. 40% reduction in proteinuria sustained out to 2 years, clear reduction in chronic eGFR slope by 1.1 mls/min/yr (p=0.037). Total eGFR slope diff 1.0 mls/min/yr, p=0.058.ir.travere.com/news-releases/โ€ฆ
account_circle
ISRO(@isro) 's Twitter Profile Photo

Chandrayaan-3 Mission:

Chandrayaan-3 ROVER:
Made in India ๐Ÿ‡ฎ๐Ÿ‡ณ
Made for the MOON๐ŸŒ–!

The Ch-3 Rover ramped down from the Lander and
India took a walk on the moon !

More updates soon.


account_circle
CanberraDSN ๐Ÿ“ก(@CanberraDSN) 's Twitter Profile Photo

So wonderful to see so many incredibly happy and proud people who have put their hearts and souls into the mission.
Congratulations ISRO ๐Ÿ‘

So wonderful to see so many incredibly happy and proud people who have put their hearts and souls into the #Chandrayaan3 mission. Congratulations @isro ๐Ÿ‘
account_circle
ISRO(@isro) 's Twitter Profile Photo

Chandrayaan-3 Mission:
'India๐Ÿ‡ฎ๐Ÿ‡ณ,
I reached my destination
and you too!'
: Chandrayaan-3

Chandrayaan-3 has successfully
soft-landed on the moon ๐ŸŒ–!.

Congratulations, India๐Ÿ‡ฎ๐Ÿ‡ณ!


account_circle